1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. COUNTRY SNAPSHOT
2.3. COUNTRY ANALYSIS
2.4. KEY GROWTH ENABLERS
2.5. KEY CHALLENGES

3. KEY ANALYTICS
3.1. IMPACT OF COVID-19 ON CARTILAGE DEGENERATION MARKET
3.2. KEY MARKET TRENDS
3.3. PORTER'S FIVE FORCES ANALYSIS
3.3.1. BUYERS POWER
3.3.2. SUPPLIERS POWER
3.3.3. SUBSTITUTION
3.3.4. NEW ENTRY
3.3.5. INDUSTRY RIVALRY
3.4. OPPORTUNITY MATRIX
3.5. VENDOR LANDSCAPE

4. MARKET BY PROCEDURE
4.1. JOINT REPLACEMENT
4.2. CHONDROPLASTY
4.3. CELL-BASED CARTILAGE RESURFACING
4.4. OSTEOCHONDRAL TRANSPLANT
4.5. MENISCUS TRANSPLANTS
4.6. OTHER PROCEDURES

5. MARKET BY APPLICATION
5.1. KNEE
5.2. HIPS
5.3. OTHER APPLICATIONS

6. MARKET BY END-USER
6.1. AMBULATORY SURGICAL CENTERS
6.2. HOSPITALS & SPECIALTY CLINICS
6.3. ACADEMIC & RESEARCH INSTITUTES

7. COMPETITIVE LANDSCAPE
7.1. KEY STRATEGIC DEVELOPMENTS
7.1.1. MERGERS & ACQUISITIONS
7.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
7.1.3. PARTNERSHIPS, CONTRACTS/AGREEMENTS & COLLABORATIONS
7.1.4. BUSINESS EXPANSIONS/ APPROVALS/ ANNOUNCEMENTS
7.2. COMPANY PROFILES
7.2.1. ANIKA THERAPEUTICS INC
7.2.2. ARTHREX INC
7.2.3. CONMED CORPORATION
7.2.4. DEPUY SYNTHES COMPANIES
7.2.5. STRYKER CORPORATION
7.2.6. ZIMMER BIOMET HOLDINGS